Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

Completed · Phase 1/Phase 2

Conditions studied: Infertility

In brief

The goal of the study is to quantitatively evaluate pituitary hormone response, follicle stimulating hormone (FSH) and luteinizing hormone (LH), to low doses of clomiphene citrate in normally fertile women.

Key facts

Study ID

NCT01340521

Run by

Milton S. Hershey Medical Center

People needed

25

Starts

1991-03-01

Expected to finish

1994-03-01

Last updated by the study team

2012-12-20

Who can join

Age: 18 and older, up to 35. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Normal cycling healthy women with known fertility
• Regular menses every 24 - 35 days
• 18 to 35 years of age
• be within 20% of ideal body weight
• normal TSH, prolactin and mid luteal phase progesterone

You may not qualify if…

• Women with Infertility issues
• Irregular menstrual cycles

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.